August 10, 2023
UNC School of Medicine researchers Angela Wahl, PhD, Balfour Sartor MD, J. Victor Garcia, PhD, and colleagues created a germ-free mouse model to evaluate the role of the microbiome in the infection, replication, and pathogenesis of HIV and Epstein-Barr virus, the virus that can cause mononucleosis and other serious diseases.
July 11, 2023
Springer recently released "Chronic Illness Care, Principles and Practice," edited by UNC Family Medicine's Timothy P. Daaleman, DO, MPH, and Margaret R. Helton, MD. Faculty members in the Department of Family Medicine, faculty across the UNC-Chapel Hill campus, and other national and international experts wrote the textbook.
June 16, 2023
Yuyang Tang, PhD, and Guochun Jiang, PhD, in the UNC School of Medicine extracted living brain tissue to conclude that specialized immune cells in the brain can harbor latent but replication-competent HIV.
May 25, 2023
The project was led by Ann M. Dennis, MD, MS, in the Division of Infectious Diseases in the Department of Medicine.
May 12, 2023
Jennifer S. Smith, PhD, at the UNC Gillings School of Global Public Health, UNC School of Medicine, and UNC Lineberger Comprehensive Cancer Center, led the phase 3 controlled trial, which showed that self-collection kits and scheduling assistance are key for reaching these populations and preventing cervical cancer.
April 3, 2023
Michael Kappelman, MD, MPH, was the lead PI on the clinical trial, which followed nearly 300 children with Crohn’s to evaluate how their conditions changed in response to anti-TNF biologic treatments alone or in combination with a second immune suppressive medication.
February 28, 2023
David Wohl, MD, and Billy Fischer, MD, published an op-ed in the News & Observer, The Charlotte Observer, and McClatchy subsidiaries on their work trying to gain a better understanding of COVID-19 through a largely observation study of thousands of volunteers in North Carolina.
November 11, 2022
A new North Carolina study called VISION is now underway to answer some of the biggest questions about COVID-19. Led by William Fischer, MD, principal investigator, and David Wohl, MD, co-lead, the study plans to enroll 7,500 COVID-positive individuals to understand the different factors that impact individual risk for key clinical outcomes including recovery from acute illness, symptom rebound, re-infection, and long COVID. Investigators explain the study more in video.
November 1, 2022
David Weber, MD, MPH, was elected as the incoming vice president of the Society for Healthcare Epidemiology of America (SHEA) during the group’s meeting held in conjunction with Infectious Diseases Week, an international conference, in Washington, D.C., in October.
October 31, 2022
Benny Joyner, MD, MPH, spoke about the rise in hospitalizations due to RSV in the inaugural podcast for UNC Children's Hospital.
October 27, 2022
UNC Institute for Global Health and Infectious Diseases and critical care experts William Fischer, MD, and David Wohl, MD, in collaboration with UNC Hospitals colleagues, will lead a Regional Emerging Special Pathogen Treatment Center funded through the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response.
August 9, 2022
The Doris Duke Charitable Foundation awarded more than $7.9 million in grants to 16 early-career physician scientists, including two from the UNC School of Medicine – Andrea Knittel, MD, PhD and Peyton Thompson, MD.